H. L. Alderson, M. P. Latimer, and P. Winn, Intravenous self-administration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus, Eur J Neurosci, vol.23, pp.2169-2175, 2006.

M. E. Avale, P. Faure, S. Pons, P. Robledo, T. Deltheil et al., Interplay of ?2* niceffects of nicotine microinjections into the ventral tegmental area of mice: Dependence on cholinergic nicotinic and dopaminergic D1 receptors, Neuropharmacology, vol.50, pp.1030-1040, 2008.

R. M. Drenan, R. Nashmi, P. I. Imoukhuede, H. Just, S. Mckinney et al., Subcellular trafficking, pentameric assembly and subunit stoichiometry of neuronal nicotinic ACh receptors containing fluorescently labeled {alpha}6 and {beta}3 subunits, Mol Pharmacol, vol.73, pp.27-41, 2008.

R. Exley, M. A. Clements, H. Hartung, J. M. Mcintosh, and S. J. Cragg, alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens, Neuropsychopharmacology, vol.33, pp.2158-2166, 2008.

L. Fattore, M. C. Martellotta, G. Cossu, M. S. Mascia, and W. Fratta, CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats, Behav Brain Res, vol.104, pp.141-146, 1999.

L. Fattore, M. C. Martellotta, G. Cossu, and W. Fratta, Gammahydroxybutyric acid: an evaluation of its rewarding properties in rats and mice, Alcohol, vol.20, pp.247-256, 2000.

L. Fattore, G. Cossu, M. C. Martellotta, S. Deiana, and W. Fratta, Baclofen antagonises intravenous self-administration of gamma-hydroxybutyric acid in mice, Neuroreport, vol.12, pp.2243-2246, 2001.

L. Fattore, G. Cossu, M. C. Martellotta, and W. Fratta, Baclofen antagonizes intravenous self-administration of nicotine in mice and rats, Alcohol Alcohol, vol.37, pp.495-498, 2002.

S. Granon, P. Faure, and J. P. Changeux, Executive and social behaviors under nicotinic receptor regulation, Proc Natl Acad Sci U S A, vol.100, pp.9596-9601, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02541881

J. Grenhoff, G. Aston-jones, and T. H. Svensson, Nicotinic effects on the firing pattern of midbrain dopamine neurons, Acta Physiol Scand, vol.128, pp.351-358, 1986.

A. J. Grottick, G. Trube, W. A. Corrigall, J. Huwyler, P. Malherbe et al., Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine, J Pharmacol Exp Ther, vol.294, pp.1112-1119, 2000.

S. Ikemoto, M. Qin, and Z. H. Liu, Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area, J Neurosci, vol.26, pp.723-730, 2006.

S. Ivanova and A. J. Greenshaw, Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron, Psychopharmacology (Berl), vol.134, pp.187-192, 1997.

J. D. Kassel, J. E. Greenstein, D. P. Evatt, M. C. Wardle, M. C. Yates et al., Smoking topography in response to denicotinized and high-yield nicotine cigarettes in adolescent smokers, J Adolesc Health, vol.40, pp.54-60, 2007.

R. Klink, A. De-kerchove-d'exaerde, M. Zoli, and J. P. Changeux, Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei, J Neurosci, vol.21, pp.1452-1463, 2001.

G. F. Koob and F. Weiss, Pharmacology of drug self-administration, Alcohol, vol.7, pp.193-197, 1990.

A. Kuzmin and B. Johansson, Reinforcing and neurochemical effects of cocaine: differences among C57, DBA, and 129 mice, Pharmacol Biochem Behav, vol.65, pp.399-406, 2000.

A. Kuzmin, E. Zvartau, G. L. Gessa, M. C. Martellotta, and W. Fratta, Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice, Pharmacol Biochem Behav, vol.41, pp.497-500, 1992.

A. Kuzmin, S. Semenova, E. E. Zvartau, and J. M. Van-ree, Enhancement of morphine self-administration in drug naive, inbred strains of mice by acute emotional stress, Eur Neuropsychopharmacol, vol.6, pp.63-68, 1996.

A. Kuzmin, S. Semenova, N. F. Ramsey, E. E. Zvartau, and J. M. Van-ree, Modulation of cocaine intravenous self-administration in drug-naive animals by dihydropyridine Ca2? channel modulators, Eur J Pharmacol, vol.295, pp.19-25, 1996.

A. V. Kuzmin, S. Semenova, M. A. Gerrits, E. E. Zvartau, and J. M. Van-ree, Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice, Eur J Pharmacol, vol.321, pp.265-271, 1997.

A. V. Kuzmin, M. A. Gerrits, E. E. Zvartau, and J. M. Van-ree, Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice, Eur Neuropsychopharmacol, vol.10, pp.447-454, 2000.

S. R. Laviolette and D. Van-der-kooy, The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour, Nat Rev Neurosci, vol.5, pp.55-65, 2004.

C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. F. Aubert et al., Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice, Science, vol.283, pp.401-404, 1999.

L. Novère, N. Zoli, M. Changeux, and J. P. , Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain, Eur J Neurosci, vol.8, pp.2428-2439, 1996.

L. Novère, N. Zoli, M. Léna, C. Ferrari, R. Picciotto et al., Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion, Neuroreport, vol.10, pp.2497-2501, 1999.

L. Novère, N. Corringer, P. J. Changeux, and J. P. , The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences, J Neurobiol, vol.53, pp.447-456, 2002.

H. M. Lesscher, E. Hoogveld, J. P. Burbach, J. M. Van-ree, and M. A. Gerrits, Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization, Eur Neuropsychopharmacol, vol.15, pp.31-37, 2005.

M. Mameli-engvall, A. Evrard, S. Pons, U. Maskos, T. H. Svensson et al., Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors, Neuron, vol.50, pp.911-921, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00176372

H. D. Mansvelder and D. S. Mcgehee, Long-term potentiation of excitatory inputs to brain reward areas by nicotine, Neuron, vol.27, pp.349-357, 2000.

H. D. Mansvelder, J. R. Keath, and D. S. Mcgehee, Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas, Neuron, vol.33, pp.905-919, 2002.

M. C. Martellotta, A. Kuzmin, E. Zvartau, G. Cossu, G. L. Gessa et al., Isradipine inhibits nicotine intravenous self-administration in drugnaive mice, Pharmacol Biochem Behav, vol.52, pp.271-274, 1995.

M. C. Martellotta, G. Cossu, L. Fattore, G. L. Gessa, and W. Fratta, Selfadministration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice, Neuroscience, vol.85, pp.327-330, 1998.

M. C. Martellotta, G. Cossu, L. Fattore, G. L. Gessa, and W. Fratta, Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice, Eur Neuropsychopharmacol, vol.8, pp.293-296, 1998.

M. C. Martellotta, C. Balducci, L. Fattore, G. Cossu, G. L. Gessa et al., Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats, Pharmacol Biochem Behav, vol.59, pp.697-702, 1998.

U. Maskos, B. E. Molles, S. Pons, M. Besson, B. P. Guiard et al., Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors, Nature, vol.436, pp.103-107, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00162546

D. S. Mcgehee and L. W. Role, Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons, Annu Rev Physiol, vol.57, pp.521-546, 1995.

L. Naldini, U. Blömer, F. H. Gage, D. Trono, and I. M. Verma, Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector, Proc Natl Acad Sci U S A, vol.93, pp.11382-11388, 1996.

R. Nashmi, M. E. Dickinson, S. Mckinney, M. Jareb, C. Labarca et al., Assembly of ?4?2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons, J Neurosci, vol.23, pp.11554-11567, 2003.

R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady et al., Chronic nicotine cell specifically upregulates functional ?4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path, J Neurosci, vol.27, pp.8202-8218, 2007.

P. A. Newhouse, A. Potter, and A. Singh, Effects of nicotinic stimulation on cognitive performance, Curr Opin Pharmacol, vol.4, pp.36-46, 2004.

N. E. Paterson, S. Semenova, F. Gasparini, and A. Markou, The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice, Psychopharmacology (Berl), vol.167, pp.257-264, 2003.

G. Paxinos and K. Franklin, The mouse brain in stereotaxic coordinates, 2001.

R. Peto, A. D. Lopez, J. Boreham, M. Thun, C. Heath et al., Mortal from smoking worldwide, Br Med Bull, vol.52, pp.12-21, 1996.

M. R. Picciotto, M. Zoli, C. Léna, A. Bessis, Y. Lallemand et al., Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain, Nature, vol.374, pp.65-67, 1995.

M. R. Picciotto, M. Zoli, R. Rimondini, C. Léna, L. M. Marubio et al., Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine, Nature, vol.391, pp.173-177, 1998.

S. Rahman, J. Zhang, and W. A. Corrigall, Local perfusion of nicotine differentially modulates somatodendritic dopamine release in the rat ventral tegmental area after nicotine preexposure, Neurochem Res, vol.29, pp.1687-1693, 2004.

T. Rasmussen and M. D. Swedberg, Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice, Pharmacol Biochem Behav, vol.60, pp.567-573, 1998.

T. Rasmussen and A. Fink-jensen, Intravenous scopolamine is potently self-administered in drug-naive mice, Neuropsychopharmacology, vol.22, pp.97-99, 2000.

T. Rasmussen, P. Sauerberg, E. B. Nielsen, M. D. Swedberg, C. Thomsen et al., Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice, Eur J Pharmacol, vol.402, pp.241-246, 2000.

M. E. Rice and S. J. Cragg, Nicotine amplifies reward-related dopamine signals in striatum, Nat Neurosci, vol.7, pp.583-584, 2004.

S. F. Robinson, E. U. Grun, J. R. Pauly, and A. C. Collins, Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice, Pharmacol Biochem Behav, vol.54, pp.587-593, 1996.

J. E. Rose and W. A. Corrigall, Nicotine self-administration in animals and humans: similarities and differences, Psychopharmacology (Berl), vol.130, pp.28-40, 1997.

R. Salas, A. Main, D. Gangitano, D. Biasi, and M. , Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit, Neuropharmacology, vol.53, pp.863-869, 2007.

O. Salminen, J. A. Drapeau, J. M. Mcintosh, A. C. Collins, M. J. Marks et al., Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice, Mol Pharmacol, vol.71, pp.1563-1571, 2007.

C. Silagy, T. Lancaster, L. Stead, D. Mant, and G. Fowler, Nicotine replacement therapy for smoking cessation, Cochrane Database Syst Rev, vol.3, p.146, 2004.

M. Solinas, L. V. Panlilio, K. Antoniou, L. A. Pappas, and S. R. Goldberg, The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug selfadministration in rats, J Pharmacol Exp Ther, vol.306, pp.93-102, 2003.

M. S. Spano, L. Fattore, G. Cossu, S. Deiana, P. Fadda et al., CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoidseeking behaviour in the rat, Br J Pharmacol, vol.143, pp.343-350, 2004.

I. P. Stolerman, C. Naylor, G. I. Elmer, and S. R. Goldberg, Discrimination and self-administration of nicotine by inbred strains of mice, Psychopharmacology (Berl), vol.141, pp.297-306, 1999.

A. R. Tapper, S. L. Mckinney, R. Nashmi, J. Schwarz, P. Deshpande et al., Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization, Science, vol.306, pp.1029-1032, 2004.

Y. Tizabi, R. L. Copeland, V. A. Louis, and R. E. Taylor, Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens, Alcohol Clin Exp Res, vol.26, pp.394-399, 2002.

S. Tolu, H. Nakatani, E. Avale, S. Pons, and U. Maskos, Towards a neuronal subtype-specific lentiviral vector system, Soc Neurosci Abstr, vol.32, pp.611-622, 2007.

C. L. Walters, S. Brown, J. P. Changeux, B. Martin, and M. I. Damaj, The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice, Psychopharmacology (Berl), vol.14, pp.1-6, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00161485

P. Whiteaker, J. M. Mcintosh, S. Luo, A. C. Collins, and M. J. Marks, 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain, Mol Pharmacol, vol.57, pp.913-925, 2000.

H. Zhang and D. Sulzer, Frequency-dependent modulation of dopamine release by nicotine, Nat Neurosci, vol.7, pp.581-582, 2004.

M. Zoli, C. Léna, M. R. Picciotto, and J. P. Changeux, Identification of four classes of brain nicotinic receptors using ?2 mutant mice, J Neurosci, vol.18, pp.4461-4472, 1998.